Biocept Stock Analysis
| BIOCQ Stock | 0.0001 0.00 0.00% |
Biocept's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Biocept's financial risk is the risk to Biocept stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Biocept's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Biocept is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Biocept to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Biocept is said to be less leveraged. If creditors hold a majority of Biocept's assets, the Company is said to be highly leveraged.
Biocept is overvalued with Real Value of 9.6E-5 and Hype Value of 1.09E-4. The main objective of Biocept stock analysis is to determine its intrinsic value, which is an estimate of what Biocept is worth, separate from its market price. There are two main types of Biocept's stock analysis: fundamental analysis and technical analysis.
The Biocept stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Biocept is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Biocept Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biocept. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Biocept Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biocept recorded a loss per share of 48.17. The entity last dividend was issued on the 8th of September 2020. The firm had 1:30 split on the 17th of May 2023. For more info on Biocept please contact the company at 858 320 8200 or go to https://biocept.com.Biocept Investment Alerts
| Biocept generated a negative expected return over the last 90 days | |
| Biocept has high historical volatility and very poor performance | |
| Biocept has some characteristics of a very speculative penny stock | |
| Biocept has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 25.86 M. Net Loss for the year was (32.09 M) with loss before overhead, payroll, taxes, and interest of (14.3 M). | |
| Biocept generates negative cash flow from operations |
Biocept Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 262.Technical Drivers
As of the 3rd of March, Biocept shows the Standard Deviation of 18.77, risk adjusted performance of (0.02), and Mean Deviation of 4.63. Biocept technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biocept Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to Biocept changes than the simple moving average.
Biocept Outstanding Bonds
Biocept issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biocept uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biocept bonds can be classified according to their maturity, which is the date when Biocept has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Biocept Predictive Daily Indicators
Biocept intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biocept stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Biocept Forecast Models
Biocept's time-series forecasting models are one of many Biocept's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biocept's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Biocept Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biocept's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biocept, which in turn will lower the firm's financial flexibility.Biocept Corporate Bonds Issued
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biocept to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Additional Tools for Biocept Stock Analysis
When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.